Since the implementation of EU MDR 2017/745, clinical evidence has become one of the biggest challenges for medical device manufacturers — and a major source of Notified Body nonconformities.
This episode breaks down the root causes behind failed submissions and offers a practical framework to fix them:
- Understanding the shift from MDD to MDR (Article 61 & Annex XIV)
- Why weak Clinical Evaluation Plans (CEPs) lead to rejection
- How to generate and analyze real, device-specific clinical data
- Integrating Post-Market Clinical Follow-up (PMCF) into your PMS system
- Maintaining a “living” Clinical Evaluation Report across the device lifecycle
Your browser does not support the audio element.
|